Background: Cardiovascular disease (CVD) is the leading cause of death in Russia. Hypertension and hyperlipidemia\nare important risk factors for CVD that are modifiable by pharmacological treatment and life-style changes. We\naimed to characterize the extent of the problem in a typical Russian city by examining the prevalence, treatment\nand control rates of hypertension and hyperlipidemia and investigating whether the specific pharmacological\nregimes used were comparable with guidelines from a country with much lower CVD rates.\nMethods: The Izhevsk Family Study II included a cross-sectional survey of a population sample of 1068 men, aged\n25ââ?¬â??60 years conducted in Izhevsk, Russia (2008ââ?¬â??2009). Blood pressure and total cholesterol were measured and\nself-reported medication use was recorded by a clinician. We compared drug treatments with the Russian and\nCanadian treatment guidelines for hypertension and hyperlipidemia.\nResults: The prevalence of hypertension was 61 % (age-standardised prevalence 51 %), with 66 % of those with\nhypertension aware of their diagnosis and 50 % of those aware taking treatment. 17 % of those taking treatment\nachieved blood pressure control. The majority (59 %) of those taking treatment were not doing so regularly.\nPrevalence of hyperlipidemia was 45 % (age-standardised prevalence 40 %), however less than 2 % of those with\nhyperlipidemia were taking any treatment. Types of lipid-lowering and anti-hypertensive medications prescribed\nwere broadly in line with Russian and Canadian guidelines.\nConclusion: The prevalence of hypertension and hyperlipidemia is high in Izhevsk while the proportion of those\ntreated and attaining treatment targets is very low. Prescribed medications were concurrent with those in Canada,\nbut adherence is a major issue.
Loading....